Literature DB >> 19353620

Renal function after hematopoietic stem cell transplantation in children.

Volkan Hazar1, Ozgul Gungor, Ayfer Gur Guven, Funda Aydin, Halide Akbas, Firat Gungor, Gulsun Tezcan, Sema Akman, Akif Yesilipek.   

Abstract

OBJECTIVES: The aim of this study was to assess glomerular and tubular renal function after HSCT in children in a prospective trial.
METHODS: Renal function was assessed prospectively before HSCT (on day -10), on days +30, +100, and at least 6 months after transplantation in 34 patients (21 females/13 males) with a mean age of 8.2 years. The following parameters were investigated: glomerular filtration rate (GFR) by creatinine clearance (CrCl), cystatin C (CysC)-based formula and plasma clearance of radiolabeled diethylenetriaminepentaacetic acid ((99m)Tc-DTPA), urinary excretion of beta(2)-microglobulin (beta(2)M), beta-N-acetylglucosaminidase (beta-NAG), fractional excretion of sodium (FE(Na)) and fractional tubular phosphate reabsorption (TP/CrCl).
RESULTS: Nine patients (26.4%) suffered from acute renal insufficiency within the first 100 days after transplantation. All patients who developed acute renal insufficiency were treated successfully without renal replacement therapy. Age, sex, primary diagnosis, sepsis, veno-occlusive disease, acute graft versus host disease, and use of vancomycin were not significant risk factors for the development of acute renal insufficiency. The medians (99m)Tc-DTPA-based GFR of patients after HSCT showed a statistically significant decrease when compared with pre-transplant values. beta-NAG excretion was significantly elevated in the first 30 days after HSCT.
CONCLUSION: Acute and chronic renal impairment can be developed in patients who undergo HSCT even though the pre-transplant renal function is in normal limits and the conditioning regimen does not include TBI. Both glomerular and tubular renal function evaluation should be part of a long-term follow-up in children following HSCT. (c) 2009 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2009        PMID: 19353620     DOI: 10.1002/pbc.22030

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  16 in total

1.  Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patients.

Authors:  Piergiorgio Cojutti; Natalia Maximova; Federico Pea
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

2.  Graft versus host disease-dependent renal dysfunction after hematopoietic stem cell transplantation.

Authors:  Yaeko Motoyoshi; Akifumi Endo; Masatoshi Takagi; Tomohiro Morio; Eisaku Ito; Michio Nagata; Shuki Mizutani
Journal:  CEN Case Rep       Date:  2014-03-21

3.  Modification and Assessment of the Bedside Pediatric Early Warning Score in the Pediatric Allogeneic Hematopoietic Cell Transplant Population.

Authors:  Daniel T Cater; Alvaro J Tori; Elizabeth A S Moser; Courtney M Rowan
Journal:  Pediatr Crit Care Med       Date:  2018-05       Impact factor: 3.624

Review 4.  Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion.

Authors:  Z Shu; S Heimfeld; D Gao
Journal:  Bone Marrow Transplant       Date:  2013-09-30       Impact factor: 5.483

5.  Cystatin C level as a marker of renal function in allogeneic hematopoietic stem cell transplantation.

Authors:  Hideharu Muto; Kazuteru Ohashi; Minoru Ando; Hideki Akiyama; Hisashi Sakamaki
Journal:  Int J Hematol       Date:  2010-03-03       Impact factor: 2.490

6.  Estimating GFR in adult patients with hematopoietic cell transplant: comparison of estimating equations with an iohexol reference standard.

Authors:  Sangeeta Hingorani; Emily Pao; Gary Schoch; Ted Gooley; George J Schwartz
Journal:  Clin J Am Soc Nephrol       Date:  2015-02-25       Impact factor: 8.237

Review 7.  Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus.

Authors:  Rupesh Raina; Rolla Abu-Arja; Sidharth Sethi; Richa Dua; Ronith Chakraborty; James T Dibb; Rajit K Basu; John Bissler; Melvin Bonilla Felix; Patrick Brophy; Timothy Bunchman; Khalid Alhasan; Dieter Haffner; Yap Hui Kim; Christopher Licht; Mignon McCulloch; Shina Menon; Ali Mirza Onder; Prajit Khooblall; Amrit Khooblall; Veronika Polishchuk; Hemalatha Rangarajan; Azmeri Sultana; Clifford Kashtan
Journal:  Pediatr Nephrol       Date:  2022-02-28       Impact factor: 3.651

8.  Estimated versus measured glomerular filtration rate in children before hematopoietic cell transplantation.

Authors:  Benjamin L Laskin; Edward Nehus; Jens Goebel; Susan Furth; Stella M Davies; Sonata Jodele
Journal:  Biol Blood Marrow Transplant       Date:  2014-07-17       Impact factor: 5.742

9.  Acute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation.

Authors:  Sarah J Kizilbash; Clifford E Kashtan; Blanche M Chavers; Qing Cao; Angela R Smith
Journal:  Biol Blood Marrow Transplant       Date:  2016-03-29       Impact factor: 5.742

10.  Early and late adverse renal effects after potentially nephrotoxic treatment for childhood cancer.

Authors:  Esmee Cm Kooijmans; Arend Bökenkamp; Nic S Tjahjadi; Jesse M Tettero; Eline van Dulmen-den Broeder; Helena Jh van der Pal; Margreet A Veening
Journal:  Cochrane Database Syst Rev       Date:  2019-03-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.